Human Formulations

Nitrofurantoin 100 mg SR Film-Coated Tablet

Nitrofurantoin 100 mg SR Film-Coated Tablet is a sustained-release film-coated tablet formulated with 100 mg. The active ingredient profile is Nitrofurantoin, placing the product in the urinary antibacterial category. Nitrofurantoin is a urinary antibacte

TabletsBeta-Lactam Tablets Single Ingredient Sustained-Release Film-Coated Tablet
Sterile injectable formulation

Product information

Product Line
Human Formulations
Category
Tablets, Beta-Lactam Tablets
Dosage Form
Sustained-Release Film-Coated Tablet
Product Type
Single Ingredient

Available strengths

100 mg

Description

Nitrofurantoin 100 mg SR Film-Coated Tablet is a sustained-release film-coated tablet formulated with 100 mg. The active ingredient profile is Nitrofurantoin, placing the product in the urinary antibacterial category. Nitrofurantoin is a urinary antibacterial that reaches therapeutically useful concentrations in urine and is used for selected susceptible urinary bacterial infections. The sustained-release designation indicates a modified-release presentation and must be described and used exactly according to the approved product literature. For website cataloguing, composition, strength, dosage form and release/coating characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad-spectrum claims. Clinical selection should depend on diagnosis, susceptibility or symptom profile, patient-specific factors and the prescriber's judgement. Prescription status, contraindications, precautions, interactions, adverse effects and dosing must be checked against the current approved label before publication. Manufacturer, licence, storage, shelf-life and market-specific regulatory details should be added only from verified product documentation.
WHO-GMP Sourced
Sterile Supply
Regulatory Documentation
Quality Assured